Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-26-006552

CEO and President acquired 4,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Levin Rami CEO and President 2026-08-14 Option exercise −4,750 4,750 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Levin Rami CEO and President 2026-08-14 Option exercise · Restricted Stock Units −4,750 14,250 D: show line 2 in the form
Loading xslF345X06/ownership.xml…